Unitaid joins Call to Action on antimicrobial resistance in Berlin

Unitaid is at the forefront of efforts to tackle antimicrobial resistance (AMR) and invests half its portfolio in innovative grants to combat resistance in low- and middle-income countries. As a member of the Interagency Coordination Group on AMR, Unitaid will be bringing its expertise in innovation and access to support the global response to AMR.

Tackling resistance is a high priority in our 2017-2021 strategy, and vital to reaching global health targets. Unitaid currently has a portfolio of US$ 500 million in resistance related projects, of which US$ 300 million have been committed after September 2016.

We work closely with partners to develop innovative diagnostics for TB drug resistance and to detect HIV among children and measuring viral load; to widen access to new and simple medicines for drug-resistant TB and first line ARVs; and to bring the best TB and HIV drugs, including child-friendly formulations. For all these innovations, Unitaid aims to secure lower prices to ensure wide and equitable access to those most in need.

If additional funding is available, Unitaid is committed to dramatically increase its investments in AMR.

Read more: “Unitaid’s work in antimicrobial resistance (AMR)“

Leveraging innovation to fight HIV/AIDS, TB and malaria in Mozambique — a photo story. (en anglais seulement)

Children with tuberculosis at Maputo Central Hospital will soon be able to receive the child-friendly TB treatment developed by the TB Alliance and its partners with funding from Unitaid. The new formulation is soluble, fruit-flavoured, and affordable. Before Unitaid’s investment, children around the world did not have access to appropriate TB medicine. As a result, caregivers often had to cut or crush tablets intended for adults. Imprecise dosing frequently led to continued illness.

A high-level Unitaid delegation visited Mozambique in September 2017 to see first-hand how the innovations it is funding in HIV testing, TB treatment and malaria prevention are making a difference in the lives of adults and children on the ground.

Read the full photo story

Landscape for HIV rapid diagnostic tests for HIV self-testing – 3rd edition – July 2016

Landscape for HIV rapid diagnostic tests for HIV self-testing – 3rd edition – July 2016

Tuberculosis diagnostics technology landscape – 5th edition

Un nouveau look pour Unitaid

This week we launched our new logo – an abstract, contemporary hummingbird in flight – to express Unitaid’s quick, agile approach to creating global health solutions. The hummingbird debuts along with our new website and our tagline, “Innovation in Global Health”.

The visual changes underline Unitaid’s mission – to fund interventions that have a catalytic effect, preparing the way for other partners to adopt and scale up innovative health products or approaches. A bird in flight embodies our work to find scaled-up solutions that take a big-picture, strategic approach.

The hummingbird’s pointed beak, wingtips and tail suggest bold, courageous focus; its motion represents active, catalytic change; and the shifting colors of its wings convey the transformation Unitaid strives to bring about.

Check out the animation below to see the Unitaid hummingbird take flight.

Video Player

Review of the Pibrentasvir patent landscape: A scoping report

Review of the Glecaprevir patent landscape: A scoping report